Insulin Signalling, Action and Secretion

The pancreas recognises a constant rise in blood glucose concentration after carbs are consumed, digested, and absorbed, and produces insulin to drive an increase in glucose level in the bloodstream, a condition known as hyperglycemia. Type 1 diabetes is caused by a significant decrease in insulin production due to beta cell death caused by autoimmunity. Type-2 diabetes is a complex condition characterised by a progressive increase in insulin resistance and a lack of insulin production, resulting in overt hyperglycemia.

 

    Related Conference of Insulin Signalling, Action and Secretion

    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    4th International Summit on Hormonal Disorders

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Aix-en-Provence, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Aix-en-Provence, France

    Insulin Signalling, Action and Secretion Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in